Evidence map›Paper›PMID 40332496›Full record

ArticleInternational journal of molecular sciences2025

Long-Read Whole-Genome Sequencing as a Tool for Variant Detection in Inherited Retinal Dystrophies.

Cristina Rodilla, Gonzalo Núñez-Moreno, Yolanda Benitez, Marta Rodríguez de Alba, Fiona Blanco-Kelly, Aroa López-Alcojor, Lidia Fernández-Caballero, Irene Perea-Romero, Marta Del Pozo-Valero, Gema García-García and 12 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Cristina RodillaDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0003-2339-6872
Gonzalo Núñez-MorenoDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Yolanda BenitezDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Marta Rodríguez de AlbaDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Fiona Blanco-KellyDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0003-0052-5651
Aroa López-AlcojorDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Lidia Fernández-CaballeroDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Irene Perea-RomeroDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0002-6402-4891
Marta Del Pozo-ValeroDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Gema García-GarcíaCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-2113-0600
Mar BalanzáCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0009-0008-3330-7339
Cristina VillaverdeDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Olga ZuritaDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Claire JubinCentre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057 Evry, France.
Cedric FundCentre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057 Evry, France.
Marc DelepineCentre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057 Evry, France.
Aurelie LeducCentre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057 Evry, France.ORCID 0009-0007-3185-5123
Jean-François DeleuzeCentre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057 Evry, France.ORCID 0000-0002-5358-4463
José M MillánCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-7211-9129
Pablo MinguezDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0003-4099-9421
Marta CortonDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Carmen AyusoDepartment of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0002-9242-7065

Funding

Centro de Investigación Biomédica en Red en Enfermedades Raras 06/07/0036European Advanced Infrastructure for Innovative Genomics (EASI-Genomics) project 824110Fundación Conchita RábagoIIS-FJD BioBank PT23/00114Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Health PI19/00321- PI20/00851- PI22/00321 and PI22/00579Organización Nacional de Ciegos Españoles (ONCE)University Chair UAM-IIS-FJD of Genomic Medicine
6 · The paper itself

Abstract

Advances in whole-genome sequencing (WGS) have significantly enhanced our ability to detect genomic variants underlying inherited diseases. In this study, we performed long-read WGS on 24 patients with inherited retinal dystrophies (IRDs) to validate the utility of nanopore sequencing in detecting genomic variations. We confirmed the presence of all previously detected variants and demonstrated that this approach allows for the precise refinement of structural variants (SVs). Furthermore, we could perform genotype phasing by sequencing only the probands, confirming that the variants were inherited in trans. Moreover, nanopore sequencing enables the detection of complex variants, such as transposon insertions and structural rearrangements. This comprehensive assessment illustrates the power of long-read sequencing in capturing diverse forms of genomic variation and in improving diagnostic accuracy in IRDs.

Indexed as

Genetic VariationRetinal DystrophiesWhole Genome SequencingFemaleHigh-Throughput Nucleotide SequencingHumansMaleNanopore Sequencinginherited retinal dystrophieslong-read sequencingnanopore sequencing

Identifiers

PMID40332496
PMCPMC12027592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.